Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Insulet (PODD) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareMedical DevicesPODD

Closing price · Nov 19, 2026 $135.34 -3.3% on the day · -60.9% over 12 months 52-week range $130.47 – $346.36
Get PODD alerts
Open-market purchases4 insiders$2.9M · last 12 months
Insiders selling2last 12 months
Reported sales$602K0 of 2 recent sales pre-planned (10b5-1)
In 15 seconds

Insiders put their own money in: $2.9M of open-market buys against $602K of sales. See how similar setups did below.

Past insider buys here: 1 of 5 beat the S&P 500 over the next 90 days. See each one ↓

Label: Strong buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
Latest open-market trade

Purchase Ashley McEvoy, CEO, President bought 1,100 shares at $147.47 ($162K).

Trade date
Aug 21, 2026
Disclosed to the SEC
Aug 24, 2026
Type
Open-market purchase (code P)

Read the original SEC filing ↗All PODD insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

PODD insider transactions (Form 4)

Open-market purchases and sales. 54 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Aug 24SEC Ashley McEvoyCEO, President Buy 1,10023,731 held (+5%) $147.47 $162K -8.2% —
Jun 4SEC Timothy C. StonesiferDirector Buy 2,7909,041 held (+45%) $143.51 $400K -5.7% 35
Jun 4SEC Luciana BorioDirector Sell 4184,329 held (−9%) $143.27 $60K -5.5% —
Jun 3SEC Elizabeth H. WeathermanDirectorFirst buy Buy 3,45010,352 held (+50%) $144.20 $497K -6.1% —
Feb 26SEC Michael R. MinogueDirectorFirst buy in 2 yrs Buy 2,03017,483 held (+13%) $246.23 $500K -45.0% —
Feb 23SEC Ashley McEvoyCEO, PresidentFirst buy Buy 4,30013,916 held (+45%) $239.35 $1.0M -43.5% —
Dec 16SEC Wayne A.I. FrederickDirector Sell 1,8512,158 held (−46%) $293.09 $543K -53.8% —
Dec 8SEC Timothy C. StonesiferDirectorFirst buy Buy 9624,591 held (+27%) $311.73 $300K -56.6% 35
Historical context

Similar past setups: not applicable. There aren't enough comparable past cases for PODD's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with PODD in the Research Lab

Pre-set to PODD's latest insider buy of $10K or more (Aug 24, 2026: Ashley McEvoy, $162K). Tap to change anything.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

PODD closeInsider buyInsider sale
100200300400DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-18EEarnings release filed 2026-05-06EEarnings release filed 2026-08-05Sold $59,887 on 2026-06-03 · Luciana BorioBought $162,217 on 2026-08-21 · Ashley McEvoyBought $299,884 on 2025-12-05 · Timothy C. StonesiferBought $499,847 on 2026-02-25 · Michael R. MinogueSold $542,510 on 2025-12-15 · Wayne A.I. FrederickBought $897,883 on 2026-06-03 · Elizabeth H. Weatherman, Timothy C. StonesiferBought $1,029,205 on 2026-02-20 · Ashley McEvoy
Bought, 12 months$2.9M
Sold, 12 months$602K
Insiders buying4
Insiders selling2

Insulet insider trading at a glance (Nov 20, 2026): in the past 12 months, 4 insiders bought $2.9M and 2 sold $602K of PODD stock on the open market; P/E 26.4 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

PODD insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $300K bought (1 trades)$300KQ4 2025: $543K sold (1 trades)Q4 2025Q1 2026: $1.5M bought (2 trades)$1.5MQ1 2026Q2 2026: $898K bought (2 trades)$898KQ2 2026: $60K sold (1 trades)Q2 2026Q3 2026: $162K bought (1 trades)$162KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$162K1—0
Q2 2026$898K2$60K1
Q1 2026$1.5M2—0
Q4 2025$300K1$543K1

Valuation, profit and volume

P/E (trailing)26.4Sector median 25.0
Market value$9.79BMedical Devices
Profit margin12.3%Revenue growth +23.5%
Volume vs. 50-day1.0×Last 5 sessions
Insiders' paper profit−$909KOn all tracked purchases -31.5%

Source: Yahoo Finance, as of Oct 18, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 4 Insulet Corporation insiders reported open-market purchases totaling $2.9M, while 2 insiders reported sales totaling $602K. Among insiders with enough purchase history to measure, Timothy C. Stonesifer (Director) has the highest Insider Score at 35. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

PODD earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Aug 5, 2026 -0.3% None -16.5%S&P -0.4% +5.9%
May 6, 2026 -16.6% None -4.3%S&P +1.1% -4.5%
Feb 18, 2026 -4.0% None +1.1%S&P +0.2% -8.8%
Nov 6, 2025 -4.4% None +1.7%S&P -1.0% -4.8%
Aug 7, 2025 -2.9% None +10.7%S&P +0.7% +13.5%
May 8, 2025 +8.3% None +17.5%S&P +0.6% +0.4%
Feb 20, 2025 +1.9% None -0.3%S&P -2.1% -5.1%
Nov 7, 2024 +1.1% None +12.0%S&P +1.2% -0.9%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

PODD news sentiment trend

Weekly headline tone (positive minus negative headlines) over 13 weeks. Green dots mark weeks with insider buying.

Not enough news
Aug 22Week of 2026-09-05: 1 headlines, 0 positive, 0 negativeWeek of 2026-09-12: 1 headlines, 0 positive, 0 negativeSep 12Week of 2026-09-26: 2 headlines, 1 positive, 0 negativeOct 3Oct 24Nov 14
Last 30 days: 0 headlines, 0 positive, 0 negative

Tone is scored from headline wording only. It describes the news, not where the stock is going.

PODD short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

Rising
20%40%60%2026-08-26: 38% of volume sold short2026-08-27: 49% of volume sold short2026-08-28: 52% of volume sold short2026-08-31: 49% of volume sold short2026-09-01: 49% of volume sold short2026-09-02: 34% of volume sold short2026-09-03: 29% of volume sold short2026-09-04: 63% of volume sold short2026-09-08: 58% of volume sold short2026-09-09: 42% of volume sold short2026-09-10: 32% of volume sold short2026-09-11: 50% of volume sold short2026-09-14: 48% of volume sold short2026-09-15: 39% of volume sold short2026-09-16: 54% of volume sold short2026-09-17: 60% of volume sold short2026-09-18: 39% of volume sold short2026-09-21: 55% of volume sold short2026-09-22: 32% of volume sold short2026-09-23: 44% of volume sold short2026-09-24: 45% of volume sold short2026-09-25: 40% of volume sold short2026-09-28: 47% of volume sold short2026-09-29: 43% of volume sold short2026-09-30: 36% of volume sold short2026-10-01: 46% of volume sold short2026-10-02: 42% of volume sold short2026-10-05: 40% of volume sold short2026-10-06: 51% of volume sold short2026-10-07: 42% of volume sold short2026-10-08: 49% of volume sold short2026-10-09: 47% of volume sold short2026-10-12: 58% of volume sold short2026-10-13: 50% of volume sold short2026-10-14: 52% of volume sold short2026-10-15: 62% of volume sold short2026-10-16: 52% of volume sold short2026-10-19: 48% of volume sold short2026-10-20: 39% of volume sold short2026-10-21: 39% of volume sold short2026-10-22: 44% of volume sold short2026-10-23: 48% of volume sold short2026-10-26: 58% of volume sold short2026-10-27: 49% of volume sold short2026-10-28: 52% of volume sold short2026-10-29: 46% of volume sold short2026-10-30: 53% of volume sold short2026-11-02: 34% of volume sold short2026-11-03: 46% of volume sold short2026-11-04: 53% of volume sold short2026-11-05: 56% of volume sold short2026-11-06: 52% of volume sold short2026-11-09: 58% of volume sold short2026-11-10: 74% of volume sold short2026-11-11: 58% of volume sold short2026-11-12: 64% of volume sold short2026-11-13: 60% of volume sold short2026-11-16: 66% of volume sold short2026-11-17: 60% of volume sold short2026-11-18: 45% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 45%20-day average: 54%Prior 2 months: 46%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded PODD

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Tina SmithSenate Sold $100,001 - $250,000 May 7, 2026May 10, 2026 -15.6%
Tina SmithSenate Sold $100,001 - $250,000 Apr 29, 2026May 10, 2026 -15.4%

PODD stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

What happened after PODD insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Aug 24, 2026Ashley McEvoyCEO, President$162K +2.2%+1.8% vs S&P-6.1%-7.0% vs S&Ppending
Jun 4, 2026Timothy C. StonesiferDirector$400K +1.9%+4.5% vs S&P+9.1%+9.6% vs S&P+1.2%-0.1% vs S&P
Jun 3, 2026Elizabeth H. WeathermanDirector$497K +5.2%+9.0% vs S&P+11.5%+11.6% vs S&P+3.5%+2.3% vs S&P
Feb 26, 2026Michael R. MinogueDirector$500K -4.2%-3.0% vs S&P-17.3%-9.2% vs S&P-41.9%-51.1% vs S&P
Feb 23, 2026Ashley McEvoyCEO, President$1.0M -1.6%-2.2% vs S&P-13.4%-9.9% vs S&P-38.3%-48.6% vs S&P
Dec 8, 2025Timothy C. StonesiferDirector$300K -1.6%-1.2% vs S&P+1.0%-0.2% vs S&P-18.8%-18.4% vs S&P

Insiders at Insulet Corporation

InsiderBoughtSoldLast filingPast buys beat S&PScore
Ashley McEvoyCEO, President $1.2M — Aug 24, 2026 — —
Timothy C. StonesiferDirector $700K — Jun 4, 2026 — 35
Michael R. MinogueDirector $500K — May 21, 2026 — —
Elizabeth H. WeathermanDirector $497K — Jun 3, 2026 — —
Wayne A.I. FrederickDirector — $543K May 21, 2026 — —
Luciana BorioDirector — $60K Jun 4, 2026 — —
Flavia PeaseCFO — — Oct 5, 2026 — —
Robert Luther HuffinesDirector — — Oct 2, 2026 — —
Jonathan Jay MazelskyDirector — — Oct 2, 2026 — —
Lisa Blair DavisSvp, Chief Hr Officer — — Aug 4, 2026 — —
Jessica HopfieldDirector — — May 21, 2026 — —
Timothy J. ScannellDirector — — May 21, 2026 — —
Michael PanosEvp And Cco — — Apr 2, 2026 — —
Eric BenjaminCOO — — Mar 3, 2026 — —
John W. KapplesGeneral Counsel — — Mar 3, 2026 — —
Prem SinghSvp, Global Operations — — Mar 3, 2026 — —
Laetitia CousinSvp, Reg, Quality & Compliance — — Mar 3, 2026 — —
Lauren BuddenGroup Vp, Cao And Controller — — Mar 3, 2026 — —

Board links: companies that share insiders with PODD

Directors and executives who filed Form 4s for PODD and another company in the last 12 months.

See the map →

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

PODD stock: common questions

Are Insulet Corporation insiders buying PODD stock?

In the past 12 months, 4 insiders reported open-market purchases of PODD worth $2.9M. The latest was CEO, President Ashley Mcevoy bought $162K of PODD at $147.47.

Are Insulet Corporation insiders selling PODD stock?

2 insiders reported sales worth $602K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is PODD's P/E ratio?

PODD trades at about 26.4 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is PODD's 52-week range?

Over the past year PODD has traded between $130.47 and $346.36. It last closed at $135.34 on Nov 19, 2026.